Literature DB >> 32789606

Biological age is a novel biomarker to predict stroke recurrence.

Carol Soriano-Tárraga1,2,3,4, Uxue Lazcano5, Jordi Jiménez-Conde5, Angel Ois6,7, Elisa Cuadrado-Godia5, Eva Giralt-Steinhauer5, Ana Rodríguez-Campello5, Alejandra Gomez-Gonzalez5, Carla Avellaneda-Gómez5, Rosa M Vivanco-Hidalgo5, Jaume Roquer5.   

Abstract

BACKGROUND: Stroke recurrence (SR) after an ischemic stroke is an important cause of death and disability. We conducted a hospital-based study to evaluate the role of biological age (b-Age: age-related DNA-methylation changes) as a risk factor for SR.
METHODS: We included 587 patients in the acute phase of stroke, assessed at one tertiary stroke center (Hospital del Mar: Barcelona, Spain). B-Age was estimated with 5 different methods based on DNA methylation, and Hannum's method was the one that better performed. We analyzed the relationships between b-Age, chronological age, sex, vascular risk factors, coronary and peripheral arterial disease, atrial fibrillation, initial neurological severity assessed by National Institutes of Health Stroke Scale (NIHSS), transient ischemic attack (TIA) in the 7 days preceding the index stroke, and symptomatic atherosclerosis. Stroke recurrence definition include: new symptoms that suggest a new ischemic event had occurred within 3 months after stroke onset and worsening by four points in the initial neurological severity (measured by National Institutes of Health Stroke Scale (NIHSS) score).
RESULTS: Logistic regression analysis associated b-Age with SR [p = 0.003; OR = 1.06 (95% CI: 1.02-1.09)], independently of chronological age [p = 0.022; OR = 0.96 (95% CI 0.94-1.00)], symptomatic atherosclerosis (stenosis > 50% in the symptomatic territory), transient ischemic attack (TIA) in the 7 days preceding the index stroke, and initial NIHSS. The b-Age of patients with SR was 2.7 years older than patients without SR.
CONCLUSIONS: Patients with SR were biologically older than those without SR. B-Age was independently associated with high risk of developing SR.

Entities:  

Keywords:  Biological age; Biomarker; DNA methylation; Epigenetics; Recurrence; Stroke

Mesh:

Substances:

Year:  2020        PMID: 32789606     DOI: 10.1007/s00415-020-10148-3

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  37 in total

Review 1.  Epigenetic modifications and human disease.

Authors:  Anna Portela; Manel Esteller
Journal:  Nat Biotechnol       Date:  2010-10       Impact factor: 54.908

2.  Biomarkers to predict clinical progression in small vessel disease strokes: prognostic role of albuminuria and oxidized LDL cholesterol.

Authors:  Elisa Cuadrado-Godia; Angel Ois; Eva Garcia-Ramallo; Eva Giralt; Sara Jimena; Miguel Angel Rubio; Ana Rodríguez-Campello; Jordi Jiménez-Conde; Jaume Roquer
Journal:  Atherosclerosis       Date:  2011-08-04       Impact factor: 5.162

3.  Distinct DNA methylomes of newborns and centenarians.

Authors:  Holger Heyn; Ning Li; Humberto J Ferreira; Sebastian Moran; David G Pisano; Antonio Gomez; Javier Diez; Jose V Sanchez-Mut; Fernando Setien; F Javier Carmona; Annibale A Puca; Sergi Sayols; Miguel A Pujana; Jordi Serra-Musach; Isabel Iglesias-Platas; Francesc Formiga; Agustin F Fernandez; Mario F Fraga; Simon C Heath; Alfonso Valencia; Ivo G Gut; Jun Wang; Manel Esteller
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-11       Impact factor: 11.205

4.  Validation and comparison of imaging-based scores for prediction of early stroke risk after transient ischaemic attack: a pooled analysis of individual-patient data from cohort studies.

Authors:  Peter J Kelly; Gregory W Albers; Anastasios Chatzikonstantinou; Gian Marco De Marchis; Julia Ferrari; Paul George; Mira Katan; Michael Knoflach; Jong S Kim; Linxin Li; Eun-Jae Lee; Jean-Marc Olivot; Francisco Purroy; Nicolas Raposo; Peter M Rothwell; Vijay K Sharma; Bo Song; Georgios Tsivgoulis; Cathal Walsh; Yuming Xu; Aine Merwick
Journal:  Lancet Neurol       Date:  2016-10-11       Impact factor: 44.182

5.  Steno-occlusive arterial disease and early neurological deterioration in acute ischemic stroke.

Authors:  Angel Ois; Jose E Martinez-Rodriguez; Elvira Munteis; Meritxell Gomis; Ana Rodríguez-Campello; Jordi Jimenez-Conde; Elisa Cuadrado-Godia; Jaume Roquer
Journal:  Cerebrovasc Dis       Date:  2008-01-23       Impact factor: 2.762

6.  Factors associated with a high risk of recurrence in patients with transient ischemic attack or minor stroke.

Authors:  Angel Ois; Meritxell Gomis; Ana Rodríguez-Campello; Elisa Cuadrado-Godia; Jordi Jiménez-Conde; Claustre Pont-Sunyer; Gracia Cuccurella; Jaume Roquer
Journal:  Stroke       Date:  2008-03-27       Impact factor: 7.914

7.  Genome-wide methylation profiles reveal quantitative views of human aging rates.

Authors:  Gregory Hannum; Justin Guinney; Ling Zhao; Li Zhang; Guy Hughes; SriniVas Sadda; Brandy Klotzle; Marina Bibikova; Jian-Bing Fan; Yuan Gao; Rob Deconde; Menzies Chen; Indika Rajapakse; Stephen Friend; Trey Ideker; Kang Zhang
Journal:  Mol Cell       Date:  2012-11-21       Impact factor: 17.970

8.  Decline in genomic DNA methylation through aging in a cohort of elderly subjects.

Authors:  Valentina Bollati; Joel Schwartz; Robert Wright; Augusto Litonjua; Letizia Tarantini; Helen Suh; David Sparrow; Pantel Vokonas; Andrea Baccarelli
Journal:  Mech Ageing Dev       Date:  2008-12-27       Impact factor: 5.432

9.  The effects of age and dietary restriction on the tissue-specific metabolome of Drosophila.

Authors:  Matthew J Laye; ViLinh Tran; Dean P Jones; Pankaj Kapahi; Daniel E L Promislow
Journal:  Aging Cell       Date:  2015-06-18       Impact factor: 9.304

10.  Underestimation of the early risk of recurrent stroke: evidence of the need for a standard definition.

Authors:  Andrew J Coull; Peter M Rothwell
Journal:  Stroke       Date:  2004-06-10       Impact factor: 7.914

View more
  6 in total

Review 1.  Epigenetic mechanisms and potential therapeutic targets in stroke.

Authors:  Kahlilia C Morris-Blanco; Anil K Chokkalla; Vijay Arruri; Soomin Jeong; Samantha M Probelsky; Raghu Vemuganti
Journal:  J Cereb Blood Flow Metab       Date:  2022-07-19       Impact factor: 6.960

2.  Dynamic epigenetic age mosaicism in the human atherosclerotic artery.

Authors:  Silvio Zaina; Manel Esteller; Isabel Gonçalves; Gertrud Lund
Journal:  PLoS One       Date:  2022-06-03       Impact factor: 3.752

Review 3.  Aging biomarkers and the brain.

Authors:  Albert T Higgins-Chen; Kyra L Thrush; Morgan E Levine
Journal:  Semin Cell Dev Biol       Date:  2021-01-25       Impact factor: 7.499

4.  The Predicted Value of Kidney Injury Molecule-1 (KIM-1) in Healthy People.

Authors:  Shanshan Peng; Na Liu; Kai Wei; Gang Li; Zheng Zou; Tao Liu; Meifang Shi; Yuan Lv; Yong Lin
Journal:  Int J Gen Med       Date:  2022-04-29

Review 5.  Protein Biomarkers in Blood Reflect the Interrelationships Between Stroke Outcome, Inflammation, Coagulation, Adhesion, Senescence and Cancer.

Authors:  Georg Fuellen; Uwe Walter; Larissa Henze; Jan Böhmert; Daniel Palmer; Soyoung Lee; Clemens A Schmitt; Henrik Rudolf; Axel Kowald
Journal:  Cell Mol Neurobiol       Date:  2022-08-11       Impact factor: 4.231

6.  A bibliometric analysis of DNA methylation in cardiovascular diseases from 2001 to 2021.

Authors:  Yan Zhang; Zijun Jia; Qingbing Zhou; Ying Zhang; Dandan Li; Yifei Qi; Fengqin Xu
Journal:  Medicine (Baltimore)       Date:  2022-08-19       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.